acylated peptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-10-18. Numbers and descriptions here follow the published literature rather than marketing material.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.
Semaglutide is a synthetic peptide of thirty-one amino acids that shares roughly ninety-four percent sequence identity with human glucagon-like peptide-1. Two substitutions resist enzymatic cleavage by dipeptidyl peptidase-4, and a fatty diacid side chain attached through a linker promotes binding to serum albumin. That albumin binding slows renal clearance and extends the circulating half-life from minutes to approximately one week. The structural changes are well established in the published literature. Whether the same modifications affect receptor signalling bias in ways that matter clinically remains an open question.
Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C187H291N45O59 | free base, without counter-ion |
| Molecular weight | About 4114 Da | peptide backbone plus attached lipid chain |
| Plasma half-life | About 165 hours | supports once-weekly dosing in humans |
| Plasma protein binding | Greater than 99 percent | attributed mainly to serum albumin |
| Receptor target | GLP-1 receptor | Gs-coupled, raises intracellular cyclic AMP |
The primary target is the GLP-1 receptor, a class B G protein-coupled receptor expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises intracellular cyclic AMP, which potentiates glucose-dependent insulin secretion and lowers glucagon release when blood glucose is elevated. Signalling in the hypothalamus and brainstem is associated with reduced appetite and slower gastric emptying. Because the insulinotropic effect depends on prevailing glucose levels, the hypoglycaemic risk of the peptide alone is described as low in most study settings. The relative contribution of peripheral and central actions remains an active research question.
Large randomised trials in adults with type 2 diabetes and in adults with obesity have reported reductions in body weight and improvements in several cardiovascular risk markers. One outcome trial found a lower incidence of major adverse cardiovascular events in participants with diabetes and established cardiovascular disease. Gastrointestinal effects such as nausea and vomiting are the most frequently reported adverse events and often diminish over time. Changes in lean body mass during weight loss are an area of ongoing investigation. Effects in adolescents and in pregnancy are less well characterised, and current labelling advises against use during pregnancy.
Two principal therapeutic variants exist under separate regulatory filings, one indicated for glycemic control in type 2 diabetes and one for chronic weight management. Both use the same active molecule; differences lie in formulation strength, titration schedule, and labeling. Regulatory agencies in the United States and European Union approved injectable forms in 2017 and 2018 respectively. An oral tablet formulation received approval later, using a carrier molecule to enhance absorption across the gastric epithelium. Labeling differs by jurisdiction and by indication.
The distinction between established facts and open questions matters here. That the peptide binds the GLP-1 receptor and stimulates insulin release in a glucose-dependent manner is well documented. How individual variability in receptor density, gastric emptying rate, and gut microbiome composition shapes response remains an active research area. Long-term outcomes beyond five years of continuous use are not yet fully characterized in published trials, and several extension studies are ongoing.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L cells after food intake. The molecule is a 31-amino-acid backbone modified at three positions to resist cleavage by dipeptidyl peptidase-4, the enzyme that degrades native GLP-1 within minutes. A lysine residue at position 26 carries a linker and a C18 fatty diacid, which promotes binding to serum albumin and slows renal clearance. These changes extend the circulating half-life from roughly two minutes to about one week in humans.
In a multicellular organism, an organ is a collection of tissues joined in a structural unit to serve a common function. In the hierarchy of life, an organ lies between tissue and an organ system. Tissues are formed from same type cells to act together in a function. Tissues of different types combine to form an organ which has a specific function. The intestinal wall, for example, is formed by epithelial tissue and smooth muscle tissue. Two or more organs working together in the execution of a specific body function form an organ system, also called a biological system or body system. An organ's tissues are broadly classified into parenchyma, the functional tissue, and stroma, the structural tissue with supportive, connective, or ancillary functions. For example, the gland tissue that produces hormones is the parenchyma, while the stroma includes the nerves that innervate the parenchyma, the blood vessels that oxygenate and nourish it and remove metabolic wastes, and the connective tissues that provide structure, placement, and anchoring. The primary tissues that form an organ generally have common embryologic origins, often arising from the same germ layer. Organs are present in most multicellular organisms. In single-celled organisms such as eukaryotes, the functional analogue of an organ is an organelle. In plants, there are three main organs. The number of organs in any organism depends on the definition used. There are approximately 79 organs in the human body; the exact number remains debated.
Improvements of the refining of ores and their extractions to smelt metals was widely used source of information for early chemists in the 16th century, among them Georg Agricola (1494–1555), who published his major work De re metallica in 1556. His work, describing highly developed and complex processes of mining metal ores and metal extraction, were the pinnacle of metallurgy during that time. His approach removed all mysticism associated with the subject, creating the practical base upon which others could and would build. The work describes the many kinds of furnaces used to smelt ore, and stimulated interest in minerals and their composition. Agricola has been described as the "father of metallurgy" and the founder of geology as a scientific discipline. Under the influence of the Scientific Revolution and its new empirical methods propounded by Sir Francis Bacon and others, a group of chemists at Oxford, Robert Boyle, Robert Hooke and John Mayow began to reshape the old alchemical traditions into a scientific discipline. Boyle in particular questioned some commonly held chemical theories and argued for chemical practitioners to be more "philosophical" and less commercially focused in The Sceptical Chemyst. He formulated Boyle's law, rejected the classical "four elements" and proposed a mechanistic alternative of atoms and chemical reactions that could be subject to rigorous experiment.
=== Hebei === In March 1982, Xi was appointed deputy party secretary of Zhengding County in Hebei. Together with Lü Yulan, the other deputy party secretary of Zhengding, Xi wrote a letter to the central government addressing the excessive requisitions that burdened local farmers. Their efforts successfully convinced the central government to reduce the annual requisition amount by 14 million kilograms. Xi also set up a pilot project for the household responsibility system in one of the poorer communes despite reservations from some in the local leadership. As the secretary of the CCP Zhengding County Committee in July 1983, Xi initiated several development projects, including the development of "Nine Articles of Zhengding talents", the construction of Changshan Park, the restoration of the Longxing Temple, the formation of a tourism company, and the establishment of the Rongguo Mansion and Zhengding Table Tennis Base. He also persuaded the China Teleplay Production Center to set the filming base of Dream of the Red Chamber in Zhengding and secured 3.5 million yuan to build Rongguo Mansion, which significantly boosted the county's tourism industry, generating 17.61 million yuan in revenue that year. Additionally, Xi invited prominent figures such as Hua Luogeng, Yu Guangyuan, Pan Chengxiao to visit Zhengding, which eventually led to the development of the county's "semi-urban" strategy, leveraging its proximity to Shijiazhuang for diverse business growth.
Sources: en.wikipedia.org
Alginic acid, also called algin, is a naturally occurring, edible polysaccharide found in brown algae. It is hydrophilic and forms a viscous gum when hydrated. When the alginic acid binds with sodium and calcium ions, the resulting salts are known as alginates. Its colour ranges from white to yellowish-brown. It is sold in filamentous, granular, and powdered forms. It is a significant component of the biofilms produced by the bacterium Pseudomonas aeruginosa, a major pathogen found in the lungs of some people who have cystic fibrosis. The biofilm and P. aeruginosa have a high resistance to antibiotics, but are susceptible to inhibition by macrophages. Alginate was discovered by the British chemical scientist E. C. C. Stanford in 1881, and he patented an extraction process for it in the same year. The alginate was extracted, in the original patent, by first soaking the algae in water or diluted acid. The resulting insoluble alginic acid is then treated with an alkaline solution such as sodium carbonate, creating sodium alginate, before finally precipitating and purifying the alginate from solution.
== Before Tiselius == Early work with the basic principle of electrophoresis dates to the early 19th century. The electrokinetic phenomenon was observed for the first time in 1807 by Russian professors Peter Ivanovich Strakhov and Ferdinand Frederic Reuß at Moscow University, who noticed that the application of a constant electric field caused clay particles dispersed in water to migrate. Experiments by Johann Wilhelm Hittorf, Walther Nernst, and Friedrich Kohlrausch to measure the properties and behavior of small ions moving through aqueous solutions under the influence of an electric field led to general mathematical descriptions of the electrochemistry of aqueous solutions. Kohlrausch created equations for varying concentrations of charged particles moving through solution, including sharp moving boundaries of migrating particles. By the beginning of the 20th century, electrochemists had found that such moving boundaries of charged particles could be created with U-shaped glass tubes. Methods of optical detection of moving boundaries in liquids had been developed by August Toepler in the 1860s; Toepler measured the schlieren (shadows) or slight variations in optical properties in inhomogeneous solutions. This method combined with the theoretical and experimental methods for creating and analysing charged moving boundaries would form the basis of Tiselius' moving-boundary electrophoresis method.
=== External relationships === The teleosts were first recognised as a distinct group by the German ichthyologist Johannes Peter Müller in 1845. The name is from Greek teleios, "complete" + osteon, "bone". Müller based this classification on certain soft tissue characteristics, which would prove to be problematic, as it did not take into account the distinguishing features of fossil teleosts. In 1966, Greenwood et al. provided a more solid classification. The oldest fossils of teleosteomorphs (the stem group from which teleosts later evolved) date back to the Triassic period (Prohalecites, Pholidophorus). However, it has been suggested that teleosts probably first evolved already during the Paleozoic era. During the Mesozoic and Cenozoic eras they diversified widely, and as a result, 96% of all living fish species are teleosts. The cladogram below shows the evolutionary relationships of the teleosts to other extant clades of bony fish, and to the four-limbed vertebrates (tetrapods) that evolved from a related group of bony fish during the Devonian period. Approximate divergence dates (in millions of years, mya) are from Near et al., 2012.
Cloud computing/big data analysis tools Artificial intelligence Machine learning Distributed ledger technologies, including blockchain and smart contracts The Internet of Things, a principle developed by Kevin Ashton that explains how simple mechanical objects can be combined into a network to broaden understanding of that object Digital communications technologies, like mobile phones Digital platforms, such as e-commerce platforms, like bighaat, agribegri, Krisikart India, which provide digital information and deliver pesticides and other agro products to farmers' doorsteps. Agro-advisory apps, such as plantix, offer quick and economical detection of crop diseases, while e-extension websites help farmers to increase their profits. Precision agriculture technologies, including Sensors, including food sensors, soil sensors, and Fuel level sensors Guidance and tracking systems (which provide Vehicle location data and are often enabled by a GPS tracking unit, GNSS, RFID, IoT, or Automatic vehicle location) Variable-rate input technologies Automatic section control Advanced imaging technologies, including satellite and drone imagery, as well as Video telematics (which may use a Dashcam), to look at temperature gradients, fertility gradients, moisture gradients, and anomalies in a field Automated machinery and agricultural robots, whose routes can be optimized using a Journey planner. Such fleets can form a localized Intelligent transportation system on the farm, often managed with a Vehicle tracking system or Fleet telematics system.
Sources: en.wikipedia.org
== Effects and symptoms == Hemoglobin in combination with normal hemoglobin (heterozygous HBD/HbA) is asymptomatic, causing no effects. Individuals have normal hemoglobin level and their red blood cells are normal spherical structure. Homozygous HbD/HbD causes mild hemolytic anemia and chronic non-progressive splenomegaly (enlargement of spleen). Heterozygous HbD/HbS causes sickle cell anemia. However, most cases of the disease are milder than the usual HbS/HbS conditions. The most serious complication noted is stroke. HbD-thalassemia causes microcytic anemia which is generally milder that in typical thalassemia.
Crosslinks are generated by a variety of exogenous and endogenous agents, including chemical compounds and high-energy radiation, and tend to interfere with normal cellular processes such as DNA replication and transcription, meaning their persistence usually compromises cell health.
Cessation of dosing with morphine creates the prototypical opioid withdrawal syndrome, which, unlike that of barbiturates, benzodiazepines, alcohol, or sedative-hypnotics, is not fatal by itself in otherwise healthy people. Acute morphine withdrawal, along with that of any other opioid, proceeds through a number of stages. Other opioids differ in the intensity and length of each, and weak opioids and mixed agonist-antagonists may have acute withdrawal syndromes that do not reach the highest level. As commonly cited, they are:
=== Biochemical pathway === The nicotinamide adenine dinucleotide (NAD+) degradation pathway in M. tuberculosis has a blockade that the scavenging pathway resulting in an excess of niacin that cannot be processed by the organism. Because of this abundance, the M. tuberculosis along with Mycobacterium canettii and varied types of Mycobacterium africanum release the excess niacin into their outside environment, in this case, the agar plate or another medium. Niacin is water-soluble, so the culture media can be tested for the presence of niacin to determine whether a Mycobacterium isolate is one of the three mentioned species. Those three species are members of the Mycobacterium tuberculosis complex.
Crossed Claisen condensations, in which the enolate and nucleophile are different esters, are also possible. An intramolecular Claisen condensation is called a Dieckmann condensation or Dieckmann cyclization, since it can be used to form rings. Esters can also undergo condensations with ketone and aldehyde enolates to give β-dicarbonyl compounds. A specific example of this is the Baker–Venkataraman rearrangement, in which an aromatic ortho-acyloxy ketone undergoes an intramolecular nucleophilic acyl substitution and subsequent rearrangement to form an aromatic β-diketone. The Chan rearrangement is another example of a rearrangement resulting from an intramolecular nucleophilic acyl substitution reaction.
Sources: en.wikipedia.org
Native GLP-1 is a short-lived peptide cleared within one to two minutes by dipeptidyl peptidase-4 and related enzymes. Semaglutide keeps the receptor-binding backbone but adds substitutions and a lipid chain. These changes block the main cleavage site and allow reversible albumin binding, extending the half-life to roughly 165 hours.
Albumin is the most abundant protein in plasma and carries molecules that bear fatty-acid chains. Binding shields the peptide from renal filtration and from peptidases, keeping a circulating reservoir. Slow release from this reservoir produces sustained receptor occupancy and supports infrequent dosing.
The insulinotropic effect is glucose-dependent, meaning secretion increases mainly when glucose is elevated. This property is often described as lowering the chance of hypoglycaemia when the compound is used alone. Other glucose-lowering agents used at the same time can still cause low blood glucose.
It is a glucagon-like peptide-1 receptor agonist, often grouped with the incretin mimetics. Its backbone is modified from the human hormone to resist enzymatic degradation and to bind albumin. These two features distinguish it from the native peptide.